Selected research
Market Structure
Global Mannitol Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Mannitol Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Mannitol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Mannitol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Mannitol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Mannitol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Mannitol Injection include Hospira, B. Braun, Fresenius Kabi, Pfizer and Jiangsu Hengrui Medicine, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Mannitol Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Mannitol Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Mannitol Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mannitol Injection market size, projected growth trends, production technologies, key applications, and end-use industries.
Mannitol Injection Segment by Company
Hospira
B. Braun
Fresenius Kabi
Pfizer
Jiangsu Hengrui Medicine
Mannitol Injection Segment by Type
5 g/100mL
10 g/100mL
15 g/100mL
20 g/100mL
25 g/100mL
Mannitol Injection Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Mannitol Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mannitol Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mannitol Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mannitol Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Mannitol Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mannitol Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Mannitol Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Mannitol Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 5 g/100mL
- 10 g/100mL
- 15 g/100mL
- 20 g/100mL
- 25 g/100mL
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Hospira
- B. Braun
- Fresenius Kabi
- Pfizer
- Jiangsu Hengrui Medicine
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Mannitol Injection Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Mannitol Injection Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Mannitol Injection Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Mannitol Injection Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Mannitol Injection Market Dynamics
- 2.1 Mannitol Injection Industry Trends
- 2.2 Mannitol Injection Industry Drivers
- 2.3 Mannitol Injection Industry Opportunities and Challenges
- 2.4 Mannitol Injection Industry Restraints
3 Mannitol Injection Market by Manufacturers
- 3.1 Global Mannitol Injection Revenue by Manufacturers (2021-2026)
- 3.2 Global Mannitol Injection Sales by Manufacturers (2021-2026)
- 3.3 Global Mannitol Injection Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Mannitol Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Mannitol Injection Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Mannitol Injection Manufacturers, Product Type & Application
- 3.7 Global Mannitol Injection Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Mannitol Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Mannitol Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 Mannitol Injection Tier 1, Tier 2, and Tier 3
4 Mannitol Injection Market by Type
- 4.1 Mannitol Injection Type Introduction
- 4.1.1 5 g/100mL
- 4.1.2 10 g/100mL
- 4.1.3 15 g/100mL
- 4.1.4 20 g/100mL
- 4.1.5 25 g/100mL
- 4.2 Global Mannitol Injection Sales by Type
- 4.2.1 Global Mannitol Injection Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Mannitol Injection Sales by Type (2021-2032)
- 4.2.3 Global Mannitol Injection Sales Market Share by Type (2021-2032)
- 4.3 Global Mannitol Injection Revenue by Type
- 4.3.1 Global Mannitol Injection Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Mannitol Injection Revenue by Type (2021-2032)
- 4.3.3 Global Mannitol Injection Revenue Market Share by Type (2021-2032)
5 Mannitol Injection Market by Application
- 5.1 Mannitol Injection Application Introduction
- 5.1.1 Hospital Pharmacies
- 5.1.2 Online Pharmacies
- 5.1.3 Retail Pharmacies
- 5.2 Global Mannitol Injection Sales by Application
- 5.2.1 Global Mannitol Injection Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Mannitol Injection Sales by Application (2021-2032)
- 5.2.3 Global Mannitol Injection Sales Market Share by Application (2021-2032)
- 5.3 Global Mannitol Injection Revenue by Application
- 5.3.1 Global Mannitol Injection Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Mannitol Injection Revenue by Application (2021-2032)
- 5.3.3 Global Mannitol Injection Revenue Market Share by Application (2021-2032)
6 Global Mannitol Injection Sales by Region
- 6.1 Global Mannitol Injection Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Mannitol Injection Sales by Region (2021-2032)
- 6.2.1 Global Mannitol Injection Sales by Region (2021-2026)
- 6.2.2 Global Mannitol Injection Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Mannitol Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Mannitol Injection Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Mannitol Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Mannitol Injection Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Mannitol Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Mannitol Injection Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Mannitol Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Mannitol Injection Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Mannitol Injection Revenue by Region
- 7.1 Global Mannitol Injection Revenue by Region
- 7.1.1 Global Mannitol Injection Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Mannitol Injection Revenue by Region (2021-2026)
- 7.1.3 Global Mannitol Injection Revenue by Region (2027-2032)
- 7.1.4 Global Mannitol Injection Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Mannitol Injection Revenue (2021-2032)
- 7.2.2 North America Mannitol Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Mannitol Injection Revenue (2021-2032)
- 7.3.2 Europe Mannitol Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Mannitol Injection Revenue (2021-2032)
- 7.4.2 Asia-Pacific Mannitol Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Mannitol Injection Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Mannitol Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Hospira
- 8.1.1 Hospira Company Information
- 8.1.2 Hospira Business Overview
- 8.1.3 Hospira Mannitol Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Hospira Mannitol Injection Product Portfolio
- 8.1.5 Hospira Recent Developments
- 8.2 B. Braun
- 8.2.1 B. Braun Company Information
- 8.2.2 B. Braun Business Overview
- 8.2.3 B. Braun Mannitol Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 B. Braun Mannitol Injection Product Portfolio
- 8.2.5 B. Braun Recent Developments
- 8.3 Fresenius Kabi
- 8.3.1 Fresenius Kabi Company Information
- 8.3.2 Fresenius Kabi Business Overview
- 8.3.3 Fresenius Kabi Mannitol Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Fresenius Kabi Mannitol Injection Product Portfolio
- 8.3.5 Fresenius Kabi Recent Developments
- 8.4 Pfizer
- 8.4.1 Pfizer Company Information
- 8.4.2 Pfizer Business Overview
- 8.4.3 Pfizer Mannitol Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Pfizer Mannitol Injection Product Portfolio
- 8.4.5 Pfizer Recent Developments
- 8.5 Jiangsu Hengrui Medicine
- 8.5.1 Jiangsu Hengrui Medicine Company Information
- 8.5.2 Jiangsu Hengrui Medicine Business Overview
- 8.5.3 Jiangsu Hengrui Medicine Mannitol Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Jiangsu Hengrui Medicine Mannitol Injection Product Portfolio
- 8.5.5 Jiangsu Hengrui Medicine Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Mannitol Injection Value Chain Analysis
- 9.1.1 Mannitol Injection Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Mannitol Injection Production Mode & Process
- 9.2 Mannitol Injection Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Mannitol Injection Distributors
- 9.2.3 Mannitol Injection Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst